124 related articles for article (PubMed ID: 14619495)
1. [Gemcitabine infusion via splenic artery for advanced pancreatic cancer].
Baba H; Endo M; Arii S
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1689-92. PubMed ID: 14619495
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial chemotherapy with gemcitabine (GEM) for unresectable pancreatic cancer].
Horiuchi H; Ishikawa H; Hiraki M; Uchida S; Yasunaga M; Ohdo M; Tamae T; Fukuda S; Hara M; Okuda K; Kinoshita H; Aoyagi S; Shirouzu K; Koganemaru M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2065-9. PubMed ID: 12484004
[TBL] [Abstract][Full Text] [Related]
3. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study.
Beane JD; Griffin KF; Levy EB; Pandalai P; Wood B; Abi-Jaoudeh N; Beresnev T; Shutack Y; Webb CC; Avital I; Rudloff U
Invest New Drugs; 2015 Feb; 33(1):109-18. PubMed ID: 25236592
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma.
Liu X; Yang X; Zhou G; Chen Y; Li C; Wang X
Medicine (Baltimore); 2016 Mar; 95(11):e3098. PubMed ID: 26986149
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.
Takamori H; Kanemitsu K; Tsuji T; Tanaka H; Chikamoto A; Nakahara O; Hiraoka T; Ikeda O; Kudo K; Imuta M; Yamashita Y
Pancreas; 2005 Apr; 30(3):223-6. PubMed ID: 15782098
[TBL] [Abstract][Full Text] [Related]
6. [A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer].
Shinchi H; Takao S; Maemura K; Noma H; Kitazono M; Ueno S; Sakoda M; Kubo F; Aikou T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1653-6. PubMed ID: 17108735
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced pancreatic cancer treated with gemcitabine hydrochloride].
Taniguchi F; Matsuda T; Tsuda T; Aikawa I
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1147-9. PubMed ID: 12938271
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.
Uwagawa T; Misawa T; Sakamoto T; Ito R; Gocho T; Shiba H; Wakiyama S; Hirohara S; Sadaoka S; Yanaga K
Ann Oncol; 2009 Feb; 20(2):239-43. PubMed ID: 18836085
[TBL] [Abstract][Full Text] [Related]
9. [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Ohta H; Doi T; Kikuchi S; Sato Y; Okuda T; Fujimi A; Kanisawa Y; Izumi K; Kitahara T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1489-92. PubMed ID: 17876153
[TBL] [Abstract][Full Text] [Related]
10. Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.
Rauch DP; Maurer CA; Aebi S; Pampallona S; Friess H; Ludwig CU; Büchler MW; Borner MM
Oncology; 2001; 60(1):43-8. PubMed ID: 11150907
[TBL] [Abstract][Full Text] [Related]
11. [Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis].
Horiuchi H; Toh U; Uchida S; Hayashi K; Kinoshita H; Yamana H; Aoyagi S; Shirouzu K; Koganemaru M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1752-4. PubMed ID: 15553704
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
[TBL] [Abstract][Full Text] [Related]
13. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.
Davis JL; Pandalai P; Ripley RT; Langan RC; Steinberg SM; Walker M; Toomey MA; Levy E; Avital I
Trials; 2011 May; 12():129. PubMed ID: 21595953
[TBL] [Abstract][Full Text] [Related]
14. A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy.
Okamoto Y; Maeba T; Kakinoki K; Okano K; Izuishi K; Wakabayashi H; Usuki H; Suzuki Y
World J Gastroenterol; 2008 Nov; 14(44):6876-80. PubMed ID: 19058319
[TBL] [Abstract][Full Text] [Related]
15. Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Aitini E; Marangolo M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):51-7. PubMed ID: 16767907
[TBL] [Abstract][Full Text] [Related]
16. A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization.
Miyanishi K; Ishiwatari H; Hayashi T; Takahashi M; Kawano Y; Takada K; Ihara H; Okuda T; Takanashi K; Takahashi S; Sato Y; Matsunaga T; Homma H; Kato J; Niitsu Y
Jpn J Clin Oncol; 2008 Apr; 38(4):268-74. PubMed ID: 18375446
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer.
Zanon C; Alabiso O; Grosso M; Buosi R; Chiappino I; Clara R; Satolli A; Zai S; Bortolini M; Botta M; Mussa A
Int J Pancreatol; 2000 Jun; 27(3):225-33. PubMed ID: 10952405
[TBL] [Abstract][Full Text] [Related]
18. Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine.
Tanaka T; Sho M; Nishiofuku H; Sakaguchi H; Inaba Y; Nakajima Y; Kichikawa K
AJR Am J Roentgenol; 2012 Jun; 198(6):1445-52. PubMed ID: 22623561
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer].
Zhong GC; Zhang XY; Chen J; Sun Y; Zhang WH; Gui YZ; Long HX; Zhu B
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):68-72. PubMed ID: 22490861
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.
An X; Li YH; Lin XB; Wang FH; Feng F; Xu RH; Jiang WQ; He YJ
Ai Zheng; 2009 Mar; 28(3):286-91. PubMed ID: 19619444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]